Skip to content

Clinical trials

Phase 2 Atherosclerosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atherosclerosis Phase: Phase 2 Clear all

111 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20014
20023
20033
20044
20055
20067
20076
20084
20097
20105
20114
20121
20134
20142
20153
20163
20174
20183
20192
20202
20216
20225
20232
20243
20253
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed79
Recruiting10
Unknown status7
Not yet recruiting4
Active, not recruiting4
Withdrawn4
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)12
GlaxoSmithKline8
University of Southern California4
Eli Lilly and Company3
NewAmsterdam Pharma3
Novartis Pharmaceuticals3
Resverlogix Corp3
AstraZeneca2
Beijing Inno Medicine Co., Ltd.2
Emory University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atherosclerosis111
Cardiovascular Diseases25
Coronary Artery Disease23
Inflammation17
Dyslipidemias14
Hypercholesterolemia8
Carotid Artery Diseases7
Heart Diseases7
Coronary Disease6
Vascular Diseases6

Trials

Showing 76 to 100 of 111. Each trial links to its page on Pharma Observatory.

11 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.